CVS Health (CVS) Tops Q2 EPS by 8c; Confirms FY23 Adj EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
CVS Health reports second quarter results
August 2, 2023 6:30 AM EDTWOONSOCKET, R.I., Aug. 2, 2023 /PRNewswire/ -- CVS Health Corporation® (NYSE: CVS) today announced operating results for the three months ended June 30, 2023.
Second quarter highlights
Total revenues increased to $88.9 billion, up 10.3% compared to prior yearGAAP diluted EPS of $1.48 and Adjusted EPS of $2.21Key financial data
Three Months Ended
... More
